Clinical trials

  • Metformin for Autosomal dominant polycystic kidney disease (ADPKD)
  • ALN-F1202 for Healthy volunteer|Hereditary angioedema
  • Durvalumab for Triple-negative breast cancer | Untreated small triple-negative breast cancer
  • Zelenectide Pevedotin for NECTIN4-amplified advanced breast cancer
  • BGB-58067 (PRMT5 inhibitor) for Advanced solid tumours with MTAP homozygous deletion and/or loss of MTAP protein expression|Non-small cell lung cancer|Metastatic glioma|Cholangiocarcinoma|Pancreatic adenocarcinoma|Biliary tract neoplasm
  • Levobupivacaine for Supratentorial brain tumour
  • NELARABINE for Melanoma|Breast cancer|Non-small cell lung cancer|Esophageal cancer
  • Lenalidomide for Primary central nervous system lymphoma
  • PF-07220060 MONOHYDRATE for Hormone receptor-positive HER2-negative breast cancer | Hormone receptor-positive HER2-positive breast cancer | Metastatic castration-resistant prostate cancer | Non-small cell lung cancer (metastatic) | Colorectal cancer (metastatic) | Liposarcoma (metastatic) | Tumors with CDK4 or CCND1 amplification
  • daratumumab for Toxic epidermal necrolysis
  • TRASTUZUMAB, PERTUZUMAB for Breast cancer|HER2-positive breast cancer
  • LUSPATERCEPT for Myelodysplastic syndrome, low-risk, non-sideroblastic (LR-MDS without ring sideroblasts)